PREVALENCE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS FOR CORONARY ARTERY DISEASE AND ELEVATED FIBRINOGEN AMONG ACTIVE MILITARY PERSONNEL IN REPUBLIC OF SERBIA: A CROSS-SECTIONAL STUDY
Traditional risk factors and elevated fibrinogen among active military personnel in Republic of Serbia
Abstract
Background: It is well known that less than 1% of the population achieves ideal cardiovascular health as well as 65% of patients do not have their conventional risk biomarkers under control. The military service has its own particularities that may contribute to the cardiovascular risk .
Methods: In order to define the preventive strategy goals, we analyzed the prevalence of traditional cardiovascular risk factors for coronary artery disease and elevated fibrinogen among active military personnel in Republic of Serbia.
Results: The cross-sectional study included 738 individuals older than 20 years, mostly between 31 and 40 years old. The mean value of SBP for the whole group was 122.39±9.42 mmHg, and for the DBP 79.94±6.56 mmHg. Among active military personnel 72.7% (533), had prehypertension and 13.8% (101) was hypertensive. Both body mass and BMI index among the observed age subgroups were found to increase with the age of the patients, as well as cholesterol values. HDL cholesterol values also differed statistically significantly between age subgroups, with the proportion of individuals with HDL less than 1.5 mmol / L in all subgroups was about 85%, the only in the 41-50 age group was lower, 76.4%. LDL cholesterol, as well as the proportion of individuals who had LDL ≥3.5, increases with the age of patients, and an identical trend was recorded with triglycerides. With aging, fibrinogen levels increased.
Conclusions: Those findings considering cardio and cerebrovascular risk factors would help to create the new approach for primary prevention for these categories of individuals.
References
2. Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther. 2011; 5:325-80. doi: 10.2147/DDDT.S14934. Epub 2011 Jun 13. PMID: 21792295; PMCID: PMC3140289.
3. Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults. Int J Cardiol. 2018; 260:196-203. PMID: 29622441 DOI: 10.1016/j.ijcard.2017.12.069.
4. Alwhaibi M, Altoaimi M, AlRuthia Y, Meraya AM, Balkhi B, Aldemerdash A, et al. Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia. Patient Prefer Adherence. 2019; 13:2111-2118. doi: 10.2147/PPA.S231873. PMID: 31853174.
5. Dakshinamurthy S, Saxena V, Kumari R, Mirza AA, Dhar M. Prevalence of hypertension and associated cardiometabolic risk factors in urban Rishikesh, Uttarakhand. J Family Med Prim Care. 2020;9(6):2931-2939. doi: 10.4103/jfmpc.jfmpc_54_20. PMID: 32984151
6. Bulelzai MA, Dubbeldam JL. Long time evolution of atherosclerotic plaques. J Theor Biol. 2012; 297:1-10. PMID: 22142625 DOI: 10.1016/j.jtbi.2011.11.023
7. Hudson SE, Feigenbaum MS, Patil N, Ding E, Ewing A, Trilk JL. Screening and socioeconomic associations of dyslipidemia in young adults. BMC Public Health. 2020 ;20(1):104. doi: 10.1186/s12889-019-8099-9. PMID: 31992243.
8. Genuth SM, Vlachos H, Brooks MM, Bantle JP, Chaitman BR, Green J, et al; BARI 2D Study Group. BARI 2D: A Reanalysis Focusing on Cardiovascular Events. Mayo Clin Proc. 2019 ;94(11):2249-2262. doi: 10.1016/j.mayocp.2019.04.015. pub 2019 Oct 4. PMID: 31590967.
9. Halle M, Berg A, Keul L, Baumstark MW. Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men. Arterioscler Thromb Vasc Bioi 1996; 16:144-48. PMID: 8548415 DOI: 10.1161/01.atv.16.1.144.
10. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998 May 13;279(18):1477-82. doi: 10.1001/jama.279.18.1477. PMID: 9600484.
11. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pencells L, Wood AM, White IR, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310-20. doi: 10.1056/NEJMoa1107477. PMID: 23034020; PMCID: PMC3714101.
12. Shah D. Healthy worker effect phenomenon. Indian J Occup Environ Med 2009; 13(2): 77–79. PMID: 20386623 DOI: 10.4103/0019-5278.55123
13. Barth SK, Kang HK, Bullman T. All-Cause Mortality Among US Veterans of the Persian Gulf War: 13-Year Follow-up. Public Health Rep. 2016 ;131(6):822-830. doi: 10.1177/0033354916676278. PMID: 28123229.
14. Shpagina LA, Ermakova MA, Volkova EA, Iakovleva SA. Clinical, functional and biochemical characteristics of arterial hypertension in military men under chronic stress. Med Tr Prom Ekol. 2008;(7):24-9. Russian. PMID: 18763613.
15. Shrestha A, Ho TE, Vie LL, Labarthe DR, Scheier LM, Lester PB et al. Comparison of Cardiovascular Health Between US Army and Civilians. J Am Heart Assoc. 2019; 8(12): e009056. doi: 10.1161/JAHA.118.009056. PMID: 31164033.
16. Ratković N, Pandrc MS, Perić V, Stojanović M, Rančić N. Relationship between plasma high-sensitivity c-reactive protein and traditional cardiovascular risk factors among active-duty military personnel in Republic of Serbia. Vojnosanit Pregl. doi: 10.2298/VSP210122030R.
17. American Heart Association. Statistical Fact Sheet-Populations. International Disease Statistics. Dallas, Tex: American Heart Association. 2003.c 2003, American Heart Association. Available online at: www.americanheart.org/presenter.jhtml identifier =3001008.
18. Ministarstvo zdravlja Republike Srbije: Vodič za dijagnostikovanje i lečenje lipidskih poremećaja; 2011, Beograd.
19. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018 Oct;14(10):576-590
20. Liberale L, Montecucco F, Tardif JC, Libby P, Camici GG. Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. Eur Heart J. 2020 Aug 14;41(31):2974-2982.
21. Ray S, Kulkarni B, Sreenivas A. Prevalence of prehypertension in young military adults and its association with overweight and dyslipidaemia. Indian J Med Res. 2011;134(2):162-7. PMID: 21911967.
22. Šipetić Grujičić Sandra, Miljuš Dragan, Soldatović Ivan, Nikolić Aleksandra, Vujčić Isidora. Prehypertension and hypertension prevalence and risk factors among adult population in Republic of Serbia: A cross-sectional study. Vojnosanitetski pregled 2020 OnLine-First Issue 00, Pages: 114-114.
23. McGraw LK, Turner BS, Stotts NA, Dracup KA. A review of cardiovascular risk factors in US military personnel. J Cardiovasc Nurs. 2008;23(4):338-44. doi: 10.1097/01.JCN.0000317437. 75081.e7. PMID: 18596497.
24. Mohsen Ibrahim M. Hypertension in Developing Countries: A Major Challenge for the Future. Curr Hypertens Rep. 2018;20(5):38. doi: 10.1007/s11906-018-0839-1. PMID: 29717393.
25. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016 ;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912. PMID: 27502908.
26. Lee JH, Seo DH, Nam MJ, Lee GH, Yang DH, Lee MJ, Choi UR, Hong S, et al. The Prevalence of Obesity and Metabolic Syndrome in the Korean Military Compared with the General Population. J Korean Med Sci. 2018;33(25): e172. doi: 10.3346/jkms.2018.33. e172. PMID: 29915523.
27. Bauduceau B, Baigts F, Bordier L, Burnat P, Ceppa F, Dumenil V, et al; Epimil group. Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study). Diabetes Metab. 2005 ;31(4 Pt 1):353-9. doi: 10.1016/s1262-3636(07)70204-5. PMID: 16369197.
28. Zhang Y, Vittinghoff E, Pletcher MJ, Allen NB, Al Hazzouri Z A, Yaffe K et al. Associations of Blood Pressure and Cholesterol Levels During Young Adulthood with Later Cardiovascular Events. J Am Coll Cardiol. 2019; 74 (3) :330-341. PMID: 31319915 DOI: 10.1016/j.jacc.2019.03.529
29. Yano Y, Reis JP, Colangelo LA, Shimbo D, Viera AJ, Allen NB, et al. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Cardiovascular Events Later in Life. JAMA. 2018;320(17):1774-1782. doi: 10.1001/jama.2018.13551. PMID: 30398601.
30. Lotfaliany M, Akbarpour S, Zafari N, Mansournia MA, Asgari S, Azizi F, et al.World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study. Int J Endocrinol Metab. 2018;16(3): e59946. doi: 10.5812/ijem.59946. PMID: 30464769.
31. Karfo R, Kangambega FM, Kabre E, Ouedraogo P, Nacro Z, Sanogo Z, et al. Prevalence of dyslipidemia in a Burkinabe military population. African Journal of Biochemistry Research. 2020; 14(1): 1-4.
32. Machlus KR, Cardenas JC, Church FC, Wolberg AS. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood. 2011;117(18):4953-63. doi: 10.1182/blood-2010-11-316885. PMID: 21355090.
33. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987;258(9):1183-6. PMID: 3626001.
34. Shankar A, Wang JJ, Rochtchina E, Mitchell P. Positive association between plasma fibrinogen level and incident hypertension among men: population-based cohort study. Hypertension. 2006 ;48(6):1043-9. doi: 10.1161/01.HYP.0000245700.13817.3c. PMID: 17000922.
35. Mauriello A, Sangiorgi G, Palmieri G, Virmani R, Holmes DR Jr, Schwartz RS, et al. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation. 2000;101(7):744-50. doi: 10.1161/01.cir.101.7.744. PMID: 10683347.
36. Maple-Brown LJ, Cunningham J, Nandi N, Hodge A, O'Dea K. Fibrinogen and associated risk factors in a high-risk population: urban Indigenous Australians, the DRUID Study. Cardiovasc Diabetol. 2010 Oct 29; 9:69. doi: 10.1186/1475-2840-9-69. PMID: 21029470; PMCID: PMC2988000.
37. Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005 12;294(14):1799-809. doi: 10.1001/jama.294.14.1799.
38. Palmieri V, Celentano A, Roman MJ, de Simone G, Best L, Lewis MR, Robbins DC, et al.; Strong Heart Study. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. Am Heart J. 2003 Mar;145(3):467-74. doi: 10.1067/mhj.2003.144. PMID: 12660670.
Copyright (c) 2021 Milena Slobodan Pandrc, Nenad Ratković , Vitomir Perić, Maja Stojanović, Vanja Kostovski , Nemanja Rančić
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.